Magenta Therapeutics Inc

DNTH14 Dec 2024
Healthcare
$23.25
+0.02 (+1.57%)
Lowest Today
$22.95
Highest Today
$23.78
Today’s Open
$23.25
Prev. Close
$23.5
52 Week High
$33.77
52 Week Low
$6.58
To Invest in Magenta Therapeutics Inc

Magenta Therapeutics Inc

Healthcare
DNTH14 Dec 2024
+0.02 (+1.57%)
1M
3M
6M
1Y
5Y
Low
$22.95
Day’s Range
High
$23.78
22.95
52 Week Low
$6.58
52-Week Range
52 Week High
$33.77
6.58
1 Day
-
1 Week
-3.43%
1 month return
-9.34%
3 month return
-18.86%
6 month return
-11.96%
1 Year return
+197.21%
3 Years return
-71.66%
5 Years return
-88.44%
10 Years return
-

Market Status

Fundamentals
Market Cap
739.92 mln
PB Ratio
2.19
PE Ratio
3.46
Enterprise Value
459.11 mln
Total Assets
179.4 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Organisation
Magenta Therapeutics Inc
Employees
53
Industry
Biotechnology
CEO
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step